首页 工具
登录
购物车
Necroptosis

Necroptosis

Necroptosis is a programmed form of necrosis, or inflammatory cell death. Conventionally, necrosis is associated with unprogrammed cell death resulting from cellular damage or infiltration by pathogens, in contrast to orderly, programmed cell death via apoptosis. The signaling pathway responsible for carrying out necroptosis is generally understood. TNFα leads to stimulation of its receptor TNFR1. TNFR1 binding protein TNFR-associated death protein TRADD and TNF receptor-associated factor 2 TRAF2 signals to RIPK1 which recruits RIPK3 forming the necrosome also named ripoptosome. Phosphorylation of MLKL by the ripoptosome drives oligomerization of MLKL, allowing MLKL to insert into and permeabilize plasma membranes and organelles. Integration of MLKL leads to the inflammatory phenotype and release of damage-associated molecular patterns (DAMPs), which elicit immune responses.
TargetMol
Cat. No. Product Name CAS No. Purity Chemical Structure
T79347 Anticancer agent 146
化合物 Anticancer agent 146
98%
TargetMol Chemical Structure Anticancer agent 146
Anticanceragent 146(compound 1.19)是一种诱导坏死(Necroptosis)的化合物,它在小鼠MDA-MB-231异种移植模型中显示出抗肿瘤活性。
T79605 RIP1 kinase inhibitor 8
化合物 RIP1 kinase inhibitor 8
2226735-54-0 98%
TargetMol Chemical Structure RIP1 kinase inhibitor 8
RIP1 kinase inhibitor 8(Compound 77)是一种高选择性的二氢吡唑(DHP)RIP1激酶抑制剂,其IC50值为20 nM,可有效抑制坏死(necrotic)细胞死亡,并在多种物种中展现出优良的药代动力学属性。
T79707 Cholicamideβ
化合物 Cholicamideβ
98%
TargetMol Chemical Structure Cholicamideβ
Cholicamideβ(compound 6)为自组装小分子癌症疫苗佐剂,能够形成细胞毒性低的病毒样颗粒。该化合物与肽抗原结合,可增强树突状细胞的抗原呈递能力,并激活抗原特异性T细胞反应。Cholicamideβ还能引发细胞凋亡(apoptosis)和坏死(necrosis)。
T79731 MLKL-IN-6
化合物 MLKL-IN-6
98%
TargetMol Chemical Structure MLKL-IN-6
MLKL-IN-6(compound P28)是一种针对Mixed Lineage Kinase domain-like(MLKL)的混合谱系激酶抑制剂,具有抗纤维化的潜力。它能够抑制MLKL的磷酸化和寡聚化,从而抑制细胞坏死、免疫细胞死亡,并减少粘附因子的表达。MLKL-IN-6展现出低细胞毒性,并可抑制肝星状细胞的激...
T80286 TP4 (Nile tilapia piscidin)
化合物 TP4 (Nile tilapia piscidin)
1429184-62-2 98%
TargetMol Chemical Structure TP4 (Nile tilapia piscidin)
TP4(Nile tilapia piscidin)是一种piscidin样的抗菌肽,其口服活性被证实。此化合物对多种革兰氏阳性及阴性菌株均有效(MIC: 0.03-10 μg/mL),并展现了溶血性。TP4还能增强免疫响应、提升抗氧化能力和改善肠道健康,助于防御细菌感染。除此之外,TP4显示抗肿瘤效果,并可通过激发癌细...
T64349 Necroptosis-IN-3
化合物Necroptosis-IN-3
547698-18-0 98.33%
TargetMol Chemical Structure Necroptosis-IN-3
Necroptosis-IN-3 (Cyclohexanecarboxamide, N-(2-thienylmethyl)-)(Compound 69) 是一种坏死性凋亡 (necroptosis) 抑制剂,抑制 TNF-α 诱导的坏死性凋亡。Necroptosis-IN-3(Compound 69) 也抑制 11β-H...
T37558 Necrostatin-5
坏死抑制素5|
337349-54-9 98.03%
TargetMol Chemical Structure Necrostatin-5
Necrostatin-5 (Nec-5)是一种RIP1激酶的选择性抑制剂,也是一种细胞坏死抑制剂,可防止TNF-α处理的fadd 缺陷Jurkat 细胞死亡,EC50值为240 nM。
T13603 CDDO-3P-Im
化合物CDDO-3P-Im
1883650-95-0 97.13%
TargetMol Chemical Structure CDDO-3P-Im
CDDO-3P-Im 是一种具有口服活性的坏死性凋亡抑制剂,具有化学预防作用。 CDDO-3P-Im 可用于有关缺血/再灌注的研究。
Anticancer agent 146
T79347
Anticanceragent 146(compound 1.19)是一种诱导坏死(Necroptosis)的化合物,它在小鼠MDA-MB-231异种移植模型中显示出抗肿瘤活性。
RIP1 kinase inhibitor 8
T79605
RIP1 kinase inhibitor 8(Compound 77)是一种高选择性的二氢吡唑(DHP)RIP1激酶抑制剂,其IC50值为20 nM,可有效抑制坏死(necrotic)细胞死亡,并在多种物种中展现出优良的药代动力学属性。
Cholicamideβ
T79707
Cholicamideβ(compound 6)为自组装小分子癌症疫苗佐剂,能够形成细胞毒性低的病毒样颗粒。该化合物与肽抗原结合,可增强树突状细胞的抗原呈递能力,并激活抗原特异性T细胞反应。Cholicamideβ还能引发细胞凋亡(apoptosis)和坏死(necrosis)。
MLKL-IN-6
T79731
MLKL-IN-6(compound P28)是一种针对Mixed Lineage Kinase domain-like(MLKL)的混合谱系激酶抑制剂,具有抗纤维化的潜力。它能够抑制MLKL的磷酸化和寡聚化,从而抑制细胞坏死、免疫细胞死亡,并减少粘附因子的表达。MLKL-IN-6展现出低细胞毒性,并可抑制肝星状细胞的激...
TP4 (Nile tilapia piscidin)
T80286
TP4(Nile tilapia piscidin)是一种piscidin样的抗菌肽,其口服活性被证实。此化合物对多种革兰氏阳性及阴性菌株均有效(MIC: 0.03-10 μg/mL),并展现了溶血性。TP4还能增强免疫响应、提升抗氧化能力和改善肠道健康,助于防御细菌感染。除此之外,TP4显示抗肿瘤效果,并可通过激发癌细...
Necroptosis-IN-3
T64349
Necroptosis-IN-3 (Cyclohexanecarboxamide, N-(2-thienylmethyl)-)(Compound 69) 是一种坏死性凋亡 (necroptosis) 抑制剂,抑制 TNF-α 诱导的坏死性凋亡。Necroptosis-IN-3(Compound 69) 也抑制 11β-H...
Necrostatin-5
T37558
Necrostatin-5 (Nec-5)是一种RIP1激酶的选择性抑制剂,也是一种细胞坏死抑制剂,可防止TNF-α处理的fadd 缺陷Jurkat 细胞死亡,EC50值为240 nM。
CDDO-3P-Im
T13603
CDDO-3P-Im 是一种具有口服活性的坏死性凋亡抑制剂,具有化学预防作用。 CDDO-3P-Im 可用于有关缺血/再灌注的研究。
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼